Our ability to reconstruct physical features from DNA is advancing, but can we ensure the privacy of “anonymised” genetic data if we can predict the face of its owner?
Genomics will change what patients expect from their provider, as well as change how physicians treat them. Before this happens, education on both sides is needed. This month we look at some of the big talking points.
The U.K. Prime Minister, Theresa May has made her first appearance in a series on industrial strategy, whereby she has pledged millions of pounds of government funding to develop artificial intelligence to transform outcomes through early diagnosis of cancer and chronic disease.
The Cleveland Clinic and Brooks Automation have said they are launching a 21,000 square foot biorepository in Cleveland’s Fairfax neighbourhood to improve researchers’ study of human tissue samples and advance personalised medicine.
A new way to simplify complex biomolecular data about tumours could in principle make it easier to prescribe the appropriate treatment for a specific patient.
Scientists have located sections of DNA that appear to play a role in controlling whether an individual’s skin burns or tans, which has laid the groundwork for genetic tests that could predict people’s responses to sunlight.
Most people don’t like going to the doctor. That’s why Theodoros Zanos, a researcher at The Feinstein Institute for Medical Research, is working on a technology that might one day be able to listen to, and decode the body’s electrical signals, catching warning signs of illness.
George Church’s idea is to “have the body and mind of a 22-year-old but the experience of a 130-year-old,” and himself might be one of the first volunteers to try the approach in humans.
A new chemotherapy regime has proved to shrink tumours twice as fast as in normal methods in patients with aggressive breast cancer carrying a faulty BRCA gene, according to a clinical trial.